Effectiveness of surgery and chemotherapy with immune checkpoint inhibitor for cardiac metastatic squamous cell carcinoma of unknown primary

手术联合免疫检查点抑制剂化疗治疗原发灶不明的心脏转移性鳞状细胞癌的疗效

阅读:2

Abstract

We present a case of squamous cell carcinoma of unknown primary (SCCUP) with metastasis to the right ventricle (RV) successfully treated through surgical resection and postoperative chemotherapy with an immune checkpoint inhibitor (ICI). A 50-year-old woman presented with dyspnea, prompting transthoracic echocardiography that revealed a mobile, irregular RV mass measuring 40 × 32 mm. Contrast-enhanced computed tomography (CT) revealed masses in the RV and the right pulmonary artery, which was totally occluded. Emergency surgical resection of both masses was performed to avoid sudden death. Histopathological analysis confirmed squamous cell carcinoma; however, the primary origin of the masses remained unidentified despite extensive evaluations, including positron emission tomography-CT. The final diagnosis was SCCUP. Immunohistochemistry indicated positive programmed cell death ligand 1, and postoperative chemotherapy with an ICI was administered. One year post-surgery, the patient remains healthy with no sign of recurrence. LEARNING OBJECTIVE: This case shows the treatment of squamous cell carcinoma of unknown primary (SCCUP) with cardiac metastasis through emergency surgery and postoperative immunotherapy. Despite the poor prognosis associated with cardiac metastatic malignant tumors and the lack of established treatment guidelines, this case highlights the potential benefits of surgical intervention and the efficacy of immunotherapy in managing cardiac metastatic SCCUP, with the patient remaining with no recurrence one-year post-surgery.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。